{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:58:07Z","timestamp":1772791087188,"version":"3.50.1"},"reference-count":72,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Wilms tumor gene WT1 is expressed at high levels in hematopoietic malignancies, such as leukemias and myelodysplastic syndromes (MDS), and in various kinds of solid tumors, including lung cancer, and it exerts an oncogenic function in these malignancies. IgM and IgG WT1 antibodies were measured by means of dot blot assay in 73 patients with hematopoietic malignancies (16 acute myeloid leukemia [AML], 11 acute lymphoid leukemia [ALL], 13 chronic myeloid leukemia [CML], and 33 MDS) and 43 healthy volunteers. Immunoglobulin IgM, IgG, and IgM+IgG WT1 antibodies were detected in 40 (54.8%), 40 (54.8%), and 24 (32.8%), respectively, of the 73 patients with hematopoietic malignancies, whereas 7 (16.2%), 2 (4.7%), and none of the 43 healthy volunteers had IgM, IgG, or IgM+IgG WT1 antibodies, respectively. Furthermore, immunoglobulin isotype class switching of WT1 antibodies from IgM to IgG occurred in conjunction with disease progression from refractory anemia (RA) to RA with excess of blasts (RAEB), and further to RAEB in transformation (RAEB-t) in MDS patients. These results showed that humoral immune responses against the WT1 protein could be elicited in patients with WT1-expressing hematopoietic malignancies, and they suggested that the helper T-cell responses needed to induce humoral immune responses and immunoglobulin isotype class switching from IgM to IgG were also generated in these patients. Our findings may provide new insight into the rationale for elicitation of cytotoxic T-cell responses against the WT1 protein in cancer immunotherapy using the WT1 vaccine.<\/jats:p>","DOI":"10.1182\/blood.v99.9.3272","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"3272-3279","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":102,"title":["Humoral immune responses against Wilms tumor gene WT1product in patients with hematopoietic malignancies"],"prefix":"10.1182","volume":"99","author":[{"given":"Olga A.","family":"Elisseeva","sequence":"first","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Oka","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoyuki","family":"Ogata","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wu","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Soma","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Tamaki","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kawakami","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Oji","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hosen","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Yamagami","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Tsukaguchi","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Udaka","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamitsu","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisei","family":"Nomura","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"From the Departments of Radiation Biology, of Molecular Medicine, and of Clinical Laboratory Science, Osaka University Medical School; Third Department of Internal Medicine, Nippon Medical School, Tokyo; Department of Medicine, Osaka Minami National Hospital; Nissay Hospital, Nippon Life Saiseikai Foundation, Osaka; Center for Adult Diseases, Osaka; Sakai Municipal Hospital, Osaka; Department of Biophysics, Kyoto University; and Osaka University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021221185148200_B1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(90)90601-A","article-title":"Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.","volume":"60","author":"Call","year":"1990","journal-title":"Cell."},{"key":"2020021221185148200_B2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/343774a0","article-title":"Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.","volume":"343","author":"Gessler","year":"1990","journal-title":"Nature."},{"key":"2020021221185148200_B3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1096\/fasebj.7.10.8393819","article-title":"The role of WT1 in Wilms tumorigenesis.","volume":"7","author":"Coppes","year":"1993","journal-title":"FASEB J."},{"key":"2020021221185148200_B4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fasebj.7.10.8393820","article-title":"The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.","volume":"7","author":"Rauscher","year":"1993","journal-title":"FASEB J."},{"key":"2020021221185148200_B5","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1126\/science.8266105","article-title":"WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.","volume":"262","author":"Haber","year":"1993","journal-title":"Science."},{"key":"2020021221185148200_B6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/humu.1380050306","article-title":"Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.","volume":"5","author":"Algar","year":"1995","journal-title":"Hum Mutat."},{"key":"2020021221185148200_B7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2","article-title":"A clinical overview of WT1 gene mutations.","volume":"9","author":"Little","year":"1997","journal-title":"Hum Mutat."},{"key":"2020021221185148200_B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0074-7696(08)60418-0","article-title":"The Wilms' tumor 1 gene: oncogene or tumor suppressor gene.","volume":"181","author":"Menke","year":"1998","journal-title":"Int Rev Cytol."},{"key":"2020021221185148200_B9","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.89.22.10984","article-title":"Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.","volume":"89","author":"Gashler","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021221185148200_B10","doi-asserted-by":"crossref","first-page":"21271","DOI":"10.1016\/S0021-9258(19)36920-0","article-title":"Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.","volume":"268","author":"Harrington","year":"1993","journal-title":"J Biol Chem."},{"key":"2020021221185148200_B11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1323141","article-title":"Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.","volume":"257","author":"Drummond","year":"1992","journal-title":"Science."},{"key":"2020021221185148200_B12","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1073\/pnas.90.12.5828","article-title":"Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.","volume":"90","author":"Werner","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021221185148200_B13","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1002\/j.1460-2075.1995.tb00148.x","article-title":"WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.","volume":"14","author":"Englert","year":"1995","journal-title":"EMBO J."},{"key":"2020021221185148200_B14","first-page":"1125","article-title":"Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.","volume":"10","author":"Goodyer","year":"1995","journal-title":"Oncogene."},{"key":"2020021221185148200_B15","doi-asserted-by":"crossref","first-page":"23785","DOI":"10.1074\/jbc.270.40.23785","article-title":"Repression of the c-myb gene by WT1 protein in T and B cell lines.","volume":"270","author":"McCann","year":"1995","journal-title":"J Biol Chem."},{"key":"2020021221185148200_B16","first-page":"5386","article-title":"Regulation of the protooncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.","volume":"55","author":"Hewitt","year":"1995","journal-title":"Cancer Res."},{"key":"2020021221185148200_B17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/excr.1998.4361","article-title":"Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.","volume":"247","author":"Li","year":"1999","journal-title":"Exp Cell Res."},{"key":"2020021221185148200_B18","first-page":"1641","article-title":"Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.","volume":"19","author":"Zhang","year":"1999","journal-title":"Anticancer Res."},{"key":"2020021221185148200_B19","doi-asserted-by":"crossref","first-page":"27047","DOI":"10.1074\/jbc.273.42.27047","article-title":"Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition.","volume":"273","author":"Guan","year":"1998","journal-title":"J Biol Chem."},{"key":"2020021221185148200_B20","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/MCB.19.3.2289","article-title":"The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation.","volume":"19","author":"Kim","year":"1999","journal-title":"Mol Cell Biol."},{"key":"2020021221185148200_B21","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1093\/emboj\/18.14.3990","article-title":"WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.","volume":"18","author":"Mayo","year":"1999","journal-title":"EMBO J."},{"key":"2020021221185148200_B22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/MCB.11.3.1707","article-title":"Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.","volume":"11","author":"Buckler","year":"1991","journal-title":"Mol Cell Biol."},{"key":"2020021221185148200_B23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng0893-415","article-title":"The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.","volume":"4","author":"Park","year":"1993","journal-title":"Nat Genet."},{"key":"2020021221185148200_B24","first-page":"1747S","article-title":"Multiple roles for the Wilms' tumor suppressor, WT1.","volume":"59","author":"Davies","year":"1999","journal-title":"Cancer Res."},{"key":"2020021221185148200_B25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.126.9.1845","article-title":"YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis.","volume":"126","author":"Moore","year":"1999","journal-title":"Development."},{"key":"2020021221185148200_B26","first-page":"405","article-title":"Expression of the Wilms' tumor gene (WT1) in human leukemias.","volume":"6","author":"Miwa","year":"1992","journal-title":"Leukemia."},{"key":"2020021221185148200_B27","first-page":"970","article-title":"Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.","volume":"7","author":"Miyagi","year":"1993","journal-title":"Leukemia."},{"key":"2020021221185148200_B28","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood."},{"key":"2020021221185148200_B29","first-page":"2138","article-title":"The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.","volume":"8","author":"Brieger","year":"1994","journal-title":"Leukemia."},{"key":"2020021221185148200_B30","first-page":"1060","article-title":"Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.","volume":"9","author":"Menssen","year":"1995","journal-title":"Leukemia."},{"key":"2020021221185148200_B31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","article-title":"Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.","volume":"89","author":"Inoue","year":"1997","journal-title":"Blood."},{"key":"2020021221185148200_B32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/07357909309018871","article-title":"Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors.","volume":"11","author":"Bruening","year":"1993","journal-title":"Cancer Invest."},{"key":"2020021221185148200_B33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ijc.2910570413","article-title":"Molecular mechanisms possibly affecting WT1 function in human ovarian tumors.","volume":"57","author":"Viel","year":"1994","journal-title":"Int J Cancer."},{"key":"2020021221185148200_B34","first-page":"3101","article-title":"Wilms' tumor suppressor gene expression in rat and human mesothelioma.","volume":"54","author":"Walker","year":"1994","journal-title":"Cancer Res."},{"key":"2020021221185148200_B35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijc.2910590116","article-title":"Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes.","volume":"59","author":"Rodeck","year":"1994","journal-title":"Int J Cancer."},{"key":"2020021221185148200_B36","first-page":"2837","article-title":"Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.","volume":"54","author":"Ladanyi","year":"1994","journal-title":"Cancer Res."},{"key":"2020021221185148200_B37","first-page":"344","article-title":"Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.","volume":"146","author":"Amin","year":"1995","journal-title":"Am J Pathol."},{"key":"2020021221185148200_B38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/gcc.2870120203","article-title":"Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression.","volume":"12","author":"Langerak","year":"1995","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021221185148200_B39","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.94.15.8132","article-title":"Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer.","volume":"94","author":"Silberstein","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021221185148200_B40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.0.CO;2-D","article-title":"Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma.","volume":"78","author":"Campbell","year":"1998","journal-title":"Int J Cancer."},{"key":"2020021221185148200_B41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1349-7006.1999.tb00733.x","article-title":"Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.","volume":"90","author":"Oji","year":"1999","journal-title":"Jpn J Cancer Res."},{"key":"2020021221185148200_B42","first-page":"357","article-title":"WT1 gene expression in human testicular germ-cell tumors.","volume":"3","author":"Harada","year":"1999","journal-title":"Mol Urol."},{"key":"2020021221185148200_B43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s004320050037","article-title":"Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens.","volume":"126","author":"Menssen","year":"2000","journal-title":"J Cancer Res Clin Oncol."},{"key":"2020021221185148200_B44","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V87.7.2878.bloodjournal8772878","article-title":"Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.","volume":"87","author":"Yamagami","year":"1996","journal-title":"Blood."},{"key":"2020021221185148200_B45","first-page":"1005","article-title":"A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.","volume":"12","author":"Algar","year":"1996","journal-title":"Oncogene."},{"key":"2020021221185148200_B46","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V91.8.2969.2969_2969_2976","article-title":"Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells.","volume":"91","author":"Inoue","year":"1998","journal-title":"Blood."},{"key":"2020021221185148200_B47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0145-2126(99)00037-5","article-title":"Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).","volume":"23","author":"Tsuboi","year":"1999","journal-title":"Leuk Res."},{"key":"2020021221185148200_B48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8","article-title":"WT1 contributes to leukemogenesis: expression patterns in 7,12-dimethylbenzanthracene (DMBA)-induced leukemia.","volume":"72","author":"Osaka","year":"1997","journal-title":"Int J Cancer."},{"key":"2020021221185148200_B49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002510050018","article-title":"Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product.","volume":"51","author":"Oka","year":"2000","journal-title":"Immunogenetics."},{"key":"2020021221185148200_B50","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","article-title":"Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.","volume":"95","author":"Gao","year":"2000","journal-title":"Blood."},{"key":"2020021221185148200_B51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood.V95.1.286","article-title":"HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide.","volume":"95","author":"Ohminami","year":"2000","journal-title":"Blood."},{"key":"2020021221185148200_B52","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.4049\/jimmunol.164.4.1873","article-title":"Cancer immunotherapy targeting Wilms' tumor gene WT1 product.","volume":"164","author":"Oka","year":"2000","journal-title":"J Immunol."},{"key":"2020021221185148200_B53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood.V96.4.1480","article-title":"Immunity to WT1 in the animal model and in patients with acute myeloid leukemia.","volume":"96","author":"Gaiger","year":"2000","journal-title":"Blood."},{"key":"2020021221185148200_B54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1006637529995","article-title":"Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination.","volume":"20","author":"Tsuboi","year":"2000","journal-title":"J Clin Immunol."},{"key":"2020021221185148200_B55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.10.040192.003153","article-title":"Tumor antigens.","volume":"10","author":"Urban","year":"1992","journal-title":"Annu Rev Immunol."},{"key":"2020021221185148200_B56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","article-title":"T cell defined tumor antigens.","volume":"9","author":"Van den Eynde","year":"1997","journal-title":"Curr Opin Immunol."},{"key":"2020021221185148200_B57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2401341","article-title":"The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.","volume":"13","author":"Tamaki","year":"1999","journal-title":"Leukemia."},{"key":"2020021221185148200_B58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem."},{"key":"2020021221185148200_B59","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021221185148200_B60","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1073\/pnas.97.9.4760","article-title":"Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.","volume":"97","author":"Jager","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021221185148200_B61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0092-8674(87)90568-X","article-title":"T cell tolerance by clonal elimination in the thymus.","volume":"49","author":"Kappler","year":"1987","journal-title":"Cell."},{"key":"2020021221185148200_B62","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0092-8674(90)90420-J","article-title":"Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.","volume":"63","author":"Webb","year":"1990","journal-title":"Cell."},{"key":"2020021221185148200_B63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/342564a0","article-title":"T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E.","volume":"342","author":"Burkly","year":"1989","journal-title":"Nature."},{"key":"2020021221185148200_B64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(91)90163-S","article-title":"Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.","volume":"65","author":"Schonrich","year":"1991","journal-title":"Cell."},{"key":"2020021221185148200_B65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0952-7915(93)90063-X","article-title":"Homing of naive, memory and effector lymphocytes.","volume":"5","author":"Mackay","year":"1993","journal-title":"Curr Opin Immunol."},{"key":"2020021221185148200_B66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","article-title":"Ablation of \u201ctolerance\u201d and induction of diabetes by virus infection in viral antigen transgenic mice.","volume":"65","author":"Ohashi","year":"1991","journal-title":"Cell."},{"key":"2020021221185148200_B67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell."},{"key":"2020021221185148200_B68","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4049\/jimmunol.155.5.2339","article-title":"Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity.","volume":"155","author":"Heath","year":"1995","journal-title":"J Immunol."},{"key":"2020021221185148200_B69","first-page":"1777","article-title":"p53 Antibodies in the sera of patients with various types of cancer: a review.","volume":"60","author":"Soussi","year":"2000","journal-title":"Cancer Res."},{"key":"2020021221185148200_B70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm0795-701","article-title":"Serum p53 antibodies as early markers of lung cancer.","volume":"1","author":"Lubin","year":"1995","journal-title":"Nat Med."},{"key":"2020021221185148200_B71","first-page":"1767","article-title":"Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.","volume":"2","author":"Trivers","year":"1996","journal-title":"Clin Cancer Res."},{"key":"2020021221185148200_B72","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.1997.15.11.3363","article-title":"High-titer HER-2\/neu protein-specific antibody can be detected in patients with early-stage breast cancer.","volume":"15","author":"Disis","year":"1997","journal-title":"J Clin Oncol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3272\/1682969\/h80902003272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3272\/1682969\/h80902003272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:22:26Z","timestamp":1682324546000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/9\/3272\/53904\/Humoral-immune-responses-against-Wilms-tumor-gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.9.3272","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}